<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis</h2>
    <div class="badge">2025-09-09T04:12:00+00:00</div>
    <ul>
      <li>2021.</li>
<li>2024;25(3):463.</li>
<li>2011;41:112-124.</li>
<li>Epub 2024 Jan 18.</li>
<li>Epub 2011 May 12.</li>
<li>2024;25(3):447-461.</li>
<li>2021 Jun 11;10(12):2578.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis\n• 2021.\n• 2024;25(3):463.\n• 2011;41:112-124.\n• Epub 2024 Jan 18.\n• Epub 2011 May 12.\n• 2024;25(3):447-461.\n• 2021 Jun 11;10(12):2578." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/amgen-kyowa-kirin-announce-top-041200878.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>